{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:15:07Z","timestamp":1778519707817,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jpag.2015.05.007","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T04:44:49Z","timestamp":1432961089000},"page":"402-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Review of Hormonal Contraception and Venous Thromboembolism in Adolescents"],"prefix":"10.1016","volume":"29","author":[{"given":"Gary M.","family":"Woods","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce A.","family":"Kerlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea E.","family":"Bonny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2015.05.007_bib1","unstructured":"Ehrlich E, Gibson TB, Mark TL: Trends in prescriptions for oral contraceptives among U.S. teenagers. Truven Health Analytics, March 2011. Available: http:\/\/truvenhealth.com\/portals\/0\/assets\/ACRS_11225_0712_OralContraceptives_RB_Web.pdf. Accessed May 19,\u00a02014."},{"issue":"Suppl 4","key":"10.1016\/j.jpag.2015.05.007_bib2","first-page":"1","article-title":"Youth risk behavior surveillance - United States, 2013","volume":"63","author":"Kann","year":"2014","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.jpag.2015.05.007_bib3","first-page":"297","article-title":"Sexual experience and contraceptive use among female teens\u2014United States, 1995, 2002, and 2006-2010","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.jpag.2015.05.007_bib4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1542\/peds.110.5.911","article-title":"National estimates of the timing of sexual maturation and racial differences among US children","volume":"110","author":"Sun","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpag.2015.05.007_bib5","first-page":"41","article-title":"Non-contraceptive benefits of oral hormonal contraceptives","volume":"11","author":"Schindler","year":"2013","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.jpag.2015.05.007_bib6","first-page":"233","article-title":"Combined oral contraceptives: health benefits beyond contraception","volume":"56","author":"Caserta","year":"2014","journal-title":"Panminerva Med"},{"key":"10.1016\/j.jpag.2015.05.007_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejogrb.2005.10.029","article-title":"Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) - a systematic enquiry and overview","volume":"125","author":"Varma","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jpag.2015.05.007_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jama.1963.03060020091034","article-title":"Oral contraception and venous thrombosis","volume":"185","author":"Tyler","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.jpag.2015.05.007_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0954-6820.1971.tb07459.x","article-title":"Oral contraceptives and thromboembolic disease: Swedish experience","volume":"190","author":"B\u00f6ttiger","year":"1971","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jpag.2015.05.007_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","article-title":"First-time use of newer oral contraceptives and the risk of venous thromboembolism","volume":"56","author":"Suissa","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2015.05.007_bib11","first-page":"61","article-title":"Oral contraceptives and risk of venous thromboembolism: impact of duration of use","volume":"57","author":"Farley","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2015.05.007_bib12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/humrep\/15.4.817","article-title":"Recurrent use of newer oral contraceptives and the risk of venous thromboembolism","volume":"15","author":"Suissa","year":"2000","journal-title":"Humanit Rep"},{"key":"10.1016\/j.jpag.2015.05.007_bib13","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/AOG.0b013e3182a91f45","article-title":"Twenty-four-month continuation of reversible contraception","volume":"122","author":"O'Neil-Callahan","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2015.05.007_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1083-3188(00)86633-4","article-title":"Comparison of continuation rates for hormonal contraception among adolescents","volume":"12","author":"Zibners","year":"1999","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpag.2015.05.007_bib15","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jpag.2015.05.007_bib16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpag.2015.05.007_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2796.1992.tb00565.x","article-title":"A prospective study of the incidence of deep-vein thrombosis within a defined urban population","volume":"232","author":"Nordstrom","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.jpag.2015.05.007_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpag.2015.05.007_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-0037-1613887","article-title":"Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale","volume":"83","author":"Oger","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib20","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jpag.2015.05.007_bib21","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor-V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jpag.2015.05.007_bib22","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement by factor-V Leiden mutation of risk of deep-vein thrombosis associated with oral-contraceptives containing 3rd-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jpag.2015.05.007_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<175::AID-AJH1>3.0.CO;2-X","article-title":"Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives","volume":"60","author":"Harris","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jpag.2015.05.007_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.contraception.2003.12.010","article-title":"The contraceptive vaginal ring (NuvaRing) and hemostasis: a comparative study","volume":"69","author":"Magnusdottir","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2015.05.007_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jpag.2015.05.007_bib28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1160\/TH04-11-0762","article-title":"Effect of oral contraceptives on the anticoagulant activity of protein S in plasma","volume":"93","author":"Koenen","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1076029608325544","article-title":"Venous thromboembolism in young female while on oral contraceptives: high frequency of inherited thrombophilia and analysis of thrombotic events in 400 Czech women","volume":"15","author":"Dulicek","year":"2009","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpag.2013.02.009","article-title":"Contraception-related venous thromboembolism in a pediatric institution","volume":"26","author":"Pillai","year":"2013","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpag.2015.05.007_bib31","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1055\/s-0037-1615947","article-title":"A cell-based model of hemostasis","volume":"85","author":"Hoffman","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2006-939552","article-title":"A cell-based model of thrombin generation","volume":"32","author":"Roberts","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00431-011-1571-x","article-title":"Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysis","volume":"171","author":"van Herrewegen","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpag.2015.05.007_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2003-42584","article-title":"Developmental hemostasis: pro- and anticoagulant systems during childhood","volume":"29","author":"Kuhle","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib35","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/jth.12372","article-title":"Developmental hemostasis: age-specific differences in the levels of hemostatic proteins","volume":"11","author":"Attard","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2010.01.045","article-title":"Mechanisms of estrogen-induced venous thromboembolism","volume":"126","author":"Tchaikovski","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.jpag.2015.05.007_bib37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-0038-1650590","article-title":"The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S","volume":"76","author":"van Wijnen","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib38","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral-contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jpag.2015.05.007_bib39","first-page":"66","article-title":"Contraception-related venous thromboembolism in adolescents","volume":"40","author":"O'Brien","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib40","doi-asserted-by":"crossref","first-page":"27852","DOI":"10.1074\/jbc.270.46.27852","article-title":"Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C","volume":"270","author":"Rosing","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpag.2015.05.007_bib41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1067\/mob.2002.121103","article-title":"Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel\/ethinyl estradiol","volume":"186","author":"Bjarnadottir","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpag.2015.05.007_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2004.09.001","article-title":"Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial","volume":"71","author":"Oddsson","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2015.05.007_bib43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2015.05.007_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/13625180500389547","article-title":"The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in the Netherlands","volume":"11","author":"Roumen","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jpag.2015.05.007_bib45","first-page":"CD003552","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","volume":"4","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpag.2015.05.007_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jemermed.2011.06.011","article-title":"The combined vaginal contraceptive ring, NuvaRing, and cerebral venous sinus thrombosis: a case report and review of the literature","volume":"42","author":"Kolacki","year":"2012","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jpag.2015.05.007_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10897-006-9069-9","article-title":"Inherited thrombophilia: key points for genetic counseling","volume":"16","author":"Varga","year":"2007","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jpag.2015.05.007_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpag.2015.05.007_bib49","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib50","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1055\/s-0038-1657712","article-title":"Risk factors for pregnancy associated venous thromboembolism","volume":"78","author":"McColl","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib51","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"Stein","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jpag.2015.05.007_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpag.2015.05.007_bib54","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High-risk of thrombosis in patients homozygous for factor-V Leiden (activated protein-C resistance)","volume":"85","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jpag.2015.05.007_bib55","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.ATV.19.3.700","article-title":"Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis","volume":"19","author":"Martinelli","year":"1999","journal-title":"Arterioscl Throm Vas"},{"key":"10.1016\/j.jpag.2015.05.007_bib56","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0037-1614442","article-title":"Incidence of venous thromboembolism in families with inherited thrombophilia","volume":"81","author":"Simioni","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jpag.2015.05.007_bib57","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pbc.23388","article-title":"Pediatric venous thromboembolism in the United States: a tertiary care complication of chronic diseases","volume":"59","author":"Setty","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpag.2015.05.007_bib58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-2004-815594","article-title":"Contraceptive choices in medically ill adolescents","volume":"21","author":"Heroux","year":"2003","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.jpag.2015.05.007_bib59","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.fertnstert.2010.11.017","article-title":"Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis","volume":"95","author":"Bedaiwy","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2015.05.007_bib60","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/archinte.158.13.1405","article-title":"Effects of the menstrual cycle on medical disorders","volume":"158","author":"Case","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpag.2015.05.007_bib61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1365-2788.2002.00360.x","article-title":"Contraception of women with intellectual disability: prevalence and determinants","volume":"46","author":"Servais","year":"2002","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.jpag.2015.05.007_bib62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.contraception.2006.06.003","article-title":"Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2015.05.007_bib63","first-page":"1","article-title":"Prevalence of obesity in the United States, 2009-2010","volume":"82","author":"Ogden","year":"2012","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jpag.2015.05.007_bib64","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-0030-1248141","article-title":"Obesity and contraception: emerging issues","volume":"28","author":"Murthy","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.jpag.2015.05.007_bib65","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1542\/peds.111.4.844","article-title":"Relative weight and race influence average age at menarche: results from two nationally representative surveys of US girls studied 25 years apart","volume":"111","author":"Anderson","year":"2003","journal-title":"Pediatrics"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318815002119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318815002119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:42:42Z","timestamp":1761054162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083318815002119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1083318815002119"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2015.05.007","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review of Hormonal Contraception and Venous Thromboembolism in Adolescents","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2015.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}